- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Journal of Neurology ; 269 (2022). - S. 3690-3699. - ISSN 0340-5354. - eISSN 1432-1459
- Schlagwort
-
Brugada-Syndrom
Sekundenherztod
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2022
- Urheber
-
Steinmetz, Karoline
Rudic, Boris
Borggrefe, Martin
Muller, Kathrin
Siebert, Reiner
Rottbauer, Wolfgang
Ludolph, Albert C.
Buckert, Dominik
Rosenbohm, Angela
- DOI
-
10.18725/OPARU-47232
- URN
-
urn:nbn:de:bsz:289-oparu-47308-2
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Steinmetz, Karoline
- Rudic, Boris
- Borggrefe, Martin
- Muller, Kathrin
- Siebert, Reiner
- Rottbauer, Wolfgang
- Ludolph, Albert C.
- Buckert, Dominik
- Rosenbohm, Angela
- Universität Ulm
Entstanden
- 2022
Ähnliche Objekte (12)
Pattern of pareses in 5q-spinal muscular atrophy
Diagnosis and management of spinal muscular atrophy : : Part 2
Defective Mitochondria Contribute to Impaired Translation in Spinal Muscular Atrophy
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
Costs of illness of spinal muscular atrophy: a systematic review
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Novel modifiers for inherited neurodegenerative disorders : spinal muscular atrophy and ataxia
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Combination disease‐modifying treatment in spinal muscular atrophy: a proposed classification
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Pattern of pareses in 5q-spinal muscular atrophy
Diagnosis and management of spinal muscular atrophy : : Part 2
Defective Mitochondria Contribute to Impaired Translation in Spinal Muscular Atrophy
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
Costs of illness of spinal muscular atrophy: a systematic review
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Novel modifiers for inherited neurodegenerative disorders : spinal muscular atrophy and ataxia
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Combination disease‐modifying treatment in spinal muscular atrophy: a proposed classification
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Pattern of pareses in 5q-spinal muscular atrophy
Diagnosis and management of spinal muscular atrophy : : Part 2
Defective Mitochondria Contribute to Impaired Translation in Spinal Muscular Atrophy
Cytoskeletal dysregulation in the motoneuron disease Spinal Muscular Atrophy (SMA)
Molecular mechanisms of cytoskeletal dysregulations in Spinal Muscular Atrophy (SMA)
Costs of illness of spinal muscular atrophy: a systematic review
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Novel modifiers for inherited neurodegenerative disorders : spinal muscular atrophy and ataxia
Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
Combination disease‐modifying treatment in spinal muscular atrophy: a proposed classification
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)